Zoll Licenses Software for AEDs from Research Center

In order to enhance its future defibrillator products, Zoll Medical Corp. (Chelmsford, MA, USA) has obtained an exclusive license for new software from the Institute of Critical Care Medicine (ICCM, Palm Springs, CA, USA) that will improve the accuracy of administering cardiopulmonary resuscitation (CPR) and defibrillation in victims of sudden cardiac arrest (SCA).

The new software will be integrated into Zoll's automated external defibrillator (AED PLUS), where it can determine whether CPR should be performed before defibrillation. The software has also been shown to predict successful defibrillation with a likelihood exceeding 90% accuracy. Improving the delivery of these early therapies might be able to increase the survival rates of SCA, currently a low 5%.

"This software development further advances the Institute's goal of expanding AEDs to become intelligent ‘resuscitation boxes,' which can provide even untrained rescuers with valuable prompting of how, and when, to perform CPR and/or defibrillation,” noted Max Harry Weil, M.D., co-inventor of the software and president of the institute. The ICCM is an international nonprofit research center.

There are more than 460,000 cases of cardiac arrest each year in the United States alone.





Related Links:
Zoll
ICCM